If future trials can demonstrate consistent efficacy and tolerability, along with a favorable impact on weight, CT-868 could offer a significant advancement in T1D care
First, he highlights striking early data from the TRIUMPH-1 trial of retatrutide, a novel GLP-3 agonist showing unprecedented weight lossup to 85 pounds over two yearsapproaching bariatric surgery outcomes, though with notable gastrointestinal side effects
This section is arguably the most practically important part of this entire guide, because GI side effects are the primary reason people discontinue either medication
Because the GLP-1 drugs are in an official drug shortage situation, and Hims can create a compounded version with the same active ingredients as Wegovy and Ozempic
Supplementation For Different Age Groups Children For parents considering glutathione supplementation for their children, its important to note that doctors think it is safe, especially in specific medical situations
